Madison Avenue Partners, LP - Q1 2023 holdings

$465 Million is the total value of Madison Avenue Partners, LP's 18 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 36.4% .

 Value Shares↓ Weighting
GHC  GRAHAM HLDGS CO$119,396,803
-1.4%
200,3840.0%25.68%
+19.7%
TBPH  THERAVANCE BIOPHARMA INC$76,082,653
-3.3%
7,012,2260.0%16.36%
+17.4%
GIII BuyG III APPAREL GROUP LTD$53,700,805
+108.8%
3,453,428
+84.1%
11.55%
+153.6%
BuySTAGWELL INC$53,035,652
+33.5%
7,147,662
+11.7%
11.41%
+62.1%
BuyMASTERBRAND INC$36,517,986
+7.2%
4,542,038
+0.6%
7.85%
+30.1%
SellORION GROUP HLDGS INC$30,126,657
-26.2%
4,496,516
-6.0%
6.48%
-10.4%
SMCI SellSUPER MICRO COMPUTER INC$24,474,748
-67.4%
229,702
-74.9%
5.26%
-60.4%
PFSW  PFSWEB INC$11,164,721
-40.2%
2,633,1890.0%2.40%
-27.4%
FHN NewFIRST HORIZON CORPORATION$10,690,652601,274
+100.0%
2.30%
AIV SellAPARTMENT INVT & MGMT COcl a$10,634,416
-12.7%
1,382,889
-19.2%
2.29%
+6.0%
OVID BuyOVID THERAPEUTICS INC$8,009,876
+58.3%
3,104,603
+14.1%
1.72%
+92.1%
FSP  FRANKLIN STR PPTYS CORP$7,919,121
-42.5%
5,044,0260.0%1.70%
-30.2%
JRVR SellJAMES RIV GROUP LTD$7,705,713
-6.7%
373,158
-5.6%
1.66%
+13.2%
MACK NewMERRIMACK PHARMACEUTICALS INC$6,797,415553,085
+100.0%
1.46%
SellSYLVAMO CORP$4,626,000
-84.7%
100,000
-83.9%
1.00%
-81.4%
CEE BuyCENTRAL & EASTERN EUROPE FD$1,704,637
+194.7%
211,030
+201.4%
0.37%
+259.8%
LNSR  LENSAR INC$1,665,925
-15.9%
669,0460.0%0.36%
+2.0%
SFE SellSAFEGUARD SCIENTIFICS INC$693,855
-51.7%
403,404
-12.9%
0.15%
-41.3%
GOSS ExitGOSSAMER BIO INC$0-711,178
-100.0%
-0.27%
MBI ExitMBIA INC$0-331,509
-100.0%
-0.76%
PTGX ExitPROTAGONIST THERAPEUTICS INC$0-406,593
-100.0%
-0.79%
Exit2SEVENTY BIO INC$0-1,199,832
-100.0%
-1.99%
ExitLEONARDO DRS INC$0-1,369,890
-100.0%
-3.10%
ExitF&G ANNUITIES & LIFE INC$0-910,020
-100.0%
-3.23%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-05-15
Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
GRAHAM HLDGS CO15Q3 202325.7%
SUPER MICRO COMPUTER INC13Q1 202324.2%
LENSAR INC12Q3 20231.7%
PG&E CORP10Q2 20227.5%
SAFEGUARD SCIENTIFICS INC10Q3 20231.9%
THERAVANCE BIOPHARMA INC9Q3 202316.4%
ADTALEM GLOBAL ED INC9Q1 202217.5%
STAGWELL INC9Q3 202311.4%
JAMES RIV GROUP LTD9Q2 202317.6%
PFSWEB INC9Q3 20236.3%

View Madison Avenue Partners, LP's complete holdings history.

Latest significant ownerships (13-D/G)
Madison Avenue Partners, LP Q1 2023 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
PFSWEB INCFebruary 14, 20232,633,18911.6%
Theravance Biopharma, Inc.February 14, 20237,012,22610.4%
James River Group Holdings, Ltd.February 14, 2022794,8372.1%
Sylvamo CorpFebruary 14, 20222,090,3354.7%
LEAF GROUP LTD.May 27, 20211,767,1934.9%
MDC PARTNERS INCFebruary 16, 20213,871,4345.3%
LENSAR, Inc.February 12, 2021637,2086.0%
SUPERIOR ENERGY SERVICES INCFebruary 14, 2020793,8585.4%

View Madison Avenue Partners, LP's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-16
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G2024-01-22
SC 13G/A2023-12-11
13F-HR2023-11-14
13F-HR2023-08-14
SC 13G2023-07-31
13F-HR2023-05-15

View Madison Avenue Partners, LP's complete filings history.

Compare quarters

Export Madison Avenue Partners, LP's holdings